In a wide manufacturing room with white walls and low ceilings, Boston Scientific employees combine components into finished ...

The stock's fall snapped a two-day winning streak.

At the end of 2023, Boston Scientific had 15 principal manufacturing facilities and owned or leased almost 11.2 million square feet across its U.S. and international properties. By the end of 2024 ...

Boston Scientific Corp. closed 9.34% short of its 52-week high of $107.17, which the company reached on February 5th.

Boston Scientific has recalled its Accolade pacemaker devices due to a manufacturing issue that could cause the devices to enter safety mode, requiring replacement.

Among major medtech stocks, Intuitive Surgical, Boston Scientific and Stryker have had an especially rough week.

Due to a manufacturing issue with the battery ... according to the FDA. Boston Scientific sent its clinician customers a letter regarding this issue in December. It recommended replacing the ...

Commanding a market capitalization of $154.8 billion, Boston Scientific Corporation (BSX) stands at the forefront of medical ...

At that time, the agency and Boston Scientific reported two deaths related to the issue that stemmed from a no-longer-used battery manufacturing process that could weaken the pacemaker’s power ...

Boston Scientific has led a $175 million funding round for the mitral valve developer 4C Medical, which is currently working ...

HealthDay News — Boston Scientific has issued a recall of Accolade ... Devices that enter Safety Mode need to be replaced. Due to a manufacturing issue, the battery underpowers the device ...